Data / Form D filings / BiologicsMD, Inc.
BiologicsMD, Inc.: Form D filings
BiologicsMD, Inc., a pharmaceuticals company in Fayetteville, AR, filed 2 Form D notices with the SEC between 2011 and 2016. The latest, on February 8, 2016, reports $400,000 sold of a $7 million offering to 1 investor.
Find out what BiologicsMD, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 535 W. Research Center Blvd #135, Fayetteville, AR, 72701
- Phone
- (479) 571-2592
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1508176
The full lists. Form D filings in Arkansas: 214 rows, $10.70, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 8, 2016 | New notice | $7,000,000 | $400,000 | $6,600,000 | 1 | Feb 1, 2016 | sec.gov |
| Jan 10, 2011 | New notice | $1,500,000 | $0 | $1,500,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ramsay Ball | Director | |
| Robyn Goforth | Executive Officer | |
| Calvin Goforth | Director, Promoter | |
| Rob Gensure | Executive Officer | |
| J. David Owens | Executive Officer, Director | |
| Lynn David Kirkpatrick | Director |
Every Form D from the week of Feb 8, 2016 · All recent filings in Arkansas · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what BiologicsMD, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.